首页> 美国卫生研究院文献>Journal of Aerosol Medicine and Pulmonary Drug Delivery >A Handling Study to Assess Use of the Respimat® Soft Mist™ Inhaler in Children Under 5 Years Old
【2h】

A Handling Study to Assess Use of the Respimat® Soft Mist™ Inhaler in Children Under 5 Years Old

机译:评估Respimat®Soft Mist™吸入器在5岁以下儿童中使用的处理研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Respimat® Soft Mist™ Inhaler (SMI) is a hand-held device that generates an aerosol with a high, fine-particle fraction, enabling efficient lung deposition. The study objective was to assess inhalation success among children using Respimat SMI, and the requirement for assistance by the parent/caregiver and/or a valved holding chamber (VHC).>Methods: This open-label study enrolled patients aged <5 years with respiratory disease and history of coughing and/or recurrent wheezing. Patients inhaled from the Respimat SMI (air only; no aerosol) using a stepwise configuration: “1” (dose released by child); “2” (dose released by parent/caregiver), and “3” (Respimat SMI with VHC, facemask, and parent/caregiver help). Co-primary endpoints included the ability to perform successful inhalation as assessed by the investigators using a standardized handling questionnaire and evaluation of the reasons for success. Inhalation profile in the successful handling configuration was verified with a pneumotachograph. Patient satisfaction and preferences were investigated in a questionnaire.>Results: Of the children aged 4 to <5 years (n=27) and 3 to <4 years (n=30), 55.6% and 30.0%, respectively, achieved success without a VHC or help; with assistance, another 29.6% and 10.0%, respectively, achieved success, and the remaining children were successful with VHC. All children aged 2 to <3 years (n=20) achieved success with the Respimat SMI and VHC. Of those aged <2 years (n=22), 95.5% had successful handling of the Respimat SMI with VHC and parent/caregiver help. Inhalation flow profiles generally confirmed the outcome of the handling assessment by the investigators. Most parent/caregiver and/or child respondents were satisfied with operation, instructions for use, handling, and ease of holding the Respimat SMI with or without a VHC.>Conclusions: The Respimat SMI is suitable for children aged <5 years; however, children aged <5 years are advised to add a VHC to complement its use.
机译:>背景: Respimat ® Soft Mist™吸入器(SMI)是一种手持式设备,可产生高细颗粒分数的气雾剂,从而使肺部有效沉积。该研究目的是评估使用Respimat SMI在儿童中的吸入成功率,以及父母/看护者和/或带阀容纳室(VHC)的协助需求。>方法: <5岁且患有呼吸系统疾病且有咳嗽和/或反复喘息史的患者。使用逐步配置从Respimat SMI(仅空气;无气雾剂)中吸入患者:“ 1”(儿童释放的剂量); “ 2”(由父母/护理人员释放的剂量)和“ 3”(带有VHC,面罩和父母/护理人员帮助的Respimat SMI)。共同主要终点包括调查人员使用标准化处理问卷评估成功吸入的能力以及成功原因的评估。用气动速度描记器验证了成功处理配置中的吸入曲线。在问卷中调查了患者的满意度和偏好。>结果:在4至<5岁(n = 27)和3至<4岁(n = 30)的儿童中,分别为55.6%和30.0%在没有VHC或帮助的情况下分别取得了成功;在帮助下,另外分别有29.6%和10.0%取得了成功,其余儿童成功获得了VHC。所有2至<3岁(n = 20)的儿童都使用Respimat SMI和VHC获得成功。在2岁以下(n = 22)的人群中,有95.5%的患者通过VHC和父母/护理人员的帮助成功处理了Respimat SMI。吸入流量概况通常证实了研究者进行处理评估的结果。大多数父母/保育者和/或儿童受访者对带或不带VHC的Respimat SMI的操作,使用说明,操作和握持的容易性都很满意。 <5年;但是,建议5岁以下的儿童添加VHC,以补充其使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号